CloudMD Software & Services (CSE: DOC) announced this morning that it is strengthening its Board of Directors this morning. The firm has appointed seasoned healthcare and tech entrepreneur Mark W. Kohler to its board.
Kohler has an extensive background in the field of North American healthcare, tech, and financial services that spans over 32 years. Currently Chairman and CEO of Exelerate Capital, Kohler is experienced in the fields of M&A activity, corporate development and strategy, and capital funding. Most recently, he was a director for that of VersaPay Corporation (TSXV: VPY) a technology firm, which last month was sold to a private equity fund for $126 million. That transaction was at a 64.5% premium at the time of announcement.
Prior to his success at VersaPay, Kohler served as executive chairman for that of QHR Corporation, where he lead the team through a transformation and re-align its healthcare and ambulatory EMR product. QHR was then sold to Loblaw Companies (TSX: L) for $170 million in 2016.
I consider CloudMD’s business model a valuable one and share their commitment to improving access to healthcare. I look forward to working alongside the leadership team and applying my energy to help create shareholder value.
Mark Kohler, Director of CloudMD
In connection with the appointment of Kohler, Donald Gordon has resigned from the Board, effective immediately.
CloudMD Software & Services last traded at $0.46 on the CSE.
FULL DISCLOSURE: CloudMD Software & Services is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover CloudMD Software & Services on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
